DexTech Medical AB, Interim report July 1, 2023 - March 31, 2024
Summary of the third quarter (2024-01-01 – 2024-03-31) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -1,5 (-1,6) · Earnings per share* SEK -0.08 (-0.08) Summary of the nine-month period (2023-07-01 – 2024-03-31) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -3,9 (-3,7) · Earnings per share* SEK -0.18 (-0.19) · Cash and cash equivalents at the end of the period amounted to MSEK 21,1 (27,1) * Before and after dilution. Earnings per share: Profit for the period divided by the average number of